Acetylcholine release inhibitor — Drug Target
All drugs that target Acetylcholine release inhibitor — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Phase 3 pipeline (2)
- DWC202405, DWC202314 · Daewoong Pharmaceutical Co. LTD. · Botulinum toxin · Neurology
DWC202405 and DWC202314 are both botulinum toxin type A serotypes. - DWC202404, DWC202314 · Daewoong Pharmaceutical Co. LTD. · Botulinum toxin · Neurology
DWC202404 and DWC202314 are botulinum toxin type A serotypes used for the treatment of various conditions.